Skip to Content

Clinical Research Sites

Agenda Health helps clinical research sites connect with strategic partners who can fuel their growth and development. We specialize in leading transactions with buyers who recognize the importance of expanding clinical trial capabilities while maintaining high standards of research integrity. Our 30+ years of expertise ensure that research centers can trek the M&A process with confidence, knowing their invaluable work will continue under new ownership.

Sell-Side Guidance for Clinical Research Sites

Managing a clinical research site requires precise operations and dedicated teams advancing medical science. When considering a transition, you need a partner who understands these uncommon challenges and can preserve the integrity of your ongoing studies. Our experienced M&A team at Agenda Health connects you with healthcare buyers who value your research capabilities and support your site’s future growth.

Meeting the Demands of Clinical Research

Clinical research sites are becoming increasingly central to the clinical development process, with nearly 70% of trials now outsourced as sponsors seek greater efficiency, specialization, and flexibility. The sector is evolving quickly, being driven by demand for decentralized trial models, therapeutic expertise, and technology-enabled execution, making it a focal point for both strategic and financial buyers. Our team understands the operational, regulatory, and growth dynamics that clinical research sites face and works closely with founders to evaluate strategic options, from capital raises to potential exits. For well-positioned operators, market conditions suggest it’s an opportune time to plan for what’s next.

Guiding Clinical Innovation & Breakthroughs

With decades worth of healthcare M&A expertise, we help clinical research site owners secure their legacies and sell their practices. Our team understands both the scientific and business aspects of your operation, linking you with buyers who share your affinity for advancing medical knowledge. From maintaining study protocols to preserving staff relationships, we guide you through the sale process with transparency and integrity, affirming your efforts to succeed under new ownership.

Thinking About Selling?

With 30+ years of combined healthcare M&A expertise and over $600M in transaction value, we’ll give you a clear, honest assessment of your business’s worth. We specialize in healthcare services and will help you understand all your options, whether you’re ready to transition now or planning for the future.

Completed Transactions

Client Success Stories in Clinical Research Sites

Erie Retina Research

Acquired by
Lexitas Pharma Services/QHP Capital
Clinical Research Sites, Featured
2026

Hear From Our Partners

Insights from Those We’ve Served

Hear from those who have gone before you and learn how our unique approach has helped healthcare organizations like yours achieve their transition goals and sell their business.

Close
Close
Close